Ray Ward Fuller
#104,320
Most Influential Person Now
Ray Ward Fuller's AcademicInfluence.com Rankings
Ray Ward Fullerbiology Degrees
Biology
#5397
World Rank
#7867
Historical Rank
Endocrinology
#46
World Rank
#54
Historical Rank
Neuroscience
#602
World Rank
#628
Historical Rank

Download Badge
Biology
Ray Ward Fuller's Degrees
- PhD Neuroscience Stanford University
- Masters Biology Stanford University
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Ray Ward Fuller Influential?
(Suggest an Edit or Addition)Ray Ward Fuller's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vasopressin/Serotonin Interactions in the Anterior Hypothalamus Control Aggressive Behavior in Golden Hamsters (1997) (490)
- Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. (1994) (259)
- Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. (1992) (222)
- Dopamine deficiency in the weaver mutant mouse (1982) (209)
- Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). (1974) (203)
- Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. (1981) (187)
- Fluoxetine, a selective inhibitor of serotonin uptake (1991) (177)
- Serotonin Uptake and Serotonin Uptake Inhibition (1990) (176)
- The pharmacologic profile of fluoxetine. (1985) (173)
- Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats (1992) (151)
- Mechanisms of effects of d-Fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus release (1988) (147)
- Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. (1988) (143)
- Inhibition of serotonin reuptake. (1977) (138)
- NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. (1991) (138)
- Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats (1981) (132)
- LOWERING OF BRAIN SEROTONIN LEVEL BY CHLORAMPHETAMINES. (1965) (125)
- Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline. (1983) (122)
- Kinetics of serotonin accumulation into synaptosomes of rat brain--effects of amphetamine and chloroamphetamines. (1973) (118)
- Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. (1980) (114)
- Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. (1975) (114)
- LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. (1983) (114)
- Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. (1975) (113)
- Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. (1989) (111)
- Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats. (1979) (102)
- Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. (1990) (100)
- Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats (1995) (99)
- Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats (1996) (99)
- Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine. (1978) (95)
- Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. (1992) (94)
- The Influence of Fluoxetine on Aggressive Behavior (1996) (94)
- Brain anoxia releases striatal dopamine in rats. (1986) (93)
- Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. (1980) (92)
- The involvement of serotonin in regulation of pituitary-adrenocortical function. (1992) (91)
- Isolation and structure/activity features of halomon-related antitumor monoterpenes from the red alga Portieria hornemannii. (1994) (85)
- Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. (1989) (84)
- Serotonin receptors and neuroendocrine responses. (1990) (84)
- Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo (1992) (81)
- Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in rats. (1976) (78)
- Basic advances in serotonin pharmacology. (1992) (77)
- Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine (1982) (76)
- Proposed animal model of attention deficit hyperactivity disorder (1994) (75)
- Lowering of epinephrine concentration in rat brain by 2,3-dichloro-alpha-methyl-benzylamine, an inhibitor of norepinephrine N-methyltransferase. (1977) (74)
- Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. (1981) (73)
- Serotonin Reuptake Blockers in Vitro and in Vivo (1987) (72)
- Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats. (1983) (71)
- Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice (1993) (70)
- The effects of quipazine on serotonin metabolism in rat brain. (1976) (70)
- Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. (1995) (68)
- Further evidence that vascular serotonin receptors are of the 5HT2 type. (1983) (66)
- Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. (1994) (65)
- Inhibition of serotonin uptake by optical isomers of fluoxetine (1985) (65)
- Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine (1983) (65)
- Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat. (1977) (64)
- Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. (1994) (64)
- Extracellular 5‐hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus l‐5‐hydroxytryptophan (1993) (63)
- Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine. (1981) (60)
- Feeding Schedule Alteration of Daily Rhythm in Tyrosine Alpha-Ketoglutarate Transaminase of Rat Liver (1968) (60)
- Fluoxetine, a Highly Selective Serotonin Reuptake Inhibitor: A Review of Preclinical Studies (1988) (59)
- Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo. (1978) (58)
- Frequent Occurrence of HIV-Inhibitory Sulphated Polysaccharides in Marine Invertebrates (1993) (57)
- Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine. (1968) (56)
- Structural relationships in the inhibition of [(3)H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines. (1980) (56)
- Selective inhibition of monoamine oxidase in rat brain mitochondria. (1970) (56)
- Use of specific serotonin uptake inhibitors as antidepressants. (1985) (55)
- Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine. (1983) (54)
- Inhibition of methyltransferases by some new analogs of S-adenosylhomocysteine. (1978) (52)
- Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents. (1985) (52)
- Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. (1990) (50)
- Role of serotonin in therapy of depression and related disorders. (1991) (50)
- Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice. (1974) (49)
- Interactions of trazodone with serotonin neurons and receptors (1984) (47)
- Serotonin oxidation by rat brain monoamine oxidase: Inhibition by 4-chloroamphetamine (1966) (46)
- Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. (1989) (46)
- The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats. (1979) (46)
- Effects of Fenfluramine and Norfenfluramine on Brain Serotonin Metabolism in Rats (1978) (46)
- Effects ofp-chloroamphetamine on brain serotonin neurons (1992) (46)
- Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole metabolism in rats. (1974) (45)
- Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. (1993) (45)
- Diffuse interstitial renal tuberculosis--an unusual cause of renal failure. (1981) (44)
- Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats. (1983) (44)
- Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats. (1979) (44)
- Substrate specificity of phenethanolamine N-methyl transferase. (1965) (43)
- Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists. (1985) (43)
- Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanisms. (1982) (42)
- Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide. (1983) (42)
- In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol. (1984) (42)
- Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats (2005) (42)
- Comparison of the oxime and the hydroxylamine derivatives of 4-chloroamphetamine as depletors of brain 5-hydroxyindoles. (1974) (42)
- Inhibition of phenethanolamine Neethyl transferase by its product, epinephrine. (1967) (41)
- Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo. (1994) (41)
- Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (1984) (40)
- Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferase. (1981) (40)
- The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats. (1978) (40)
- Fluoxetine: A serotonergic appetite suppressant drug (1989) (39)
- Sympathetic noradrenergic innervation of guinea-pig liver: histofluorescence and pharmacological studies. (1981) (39)
- Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. (1985) (39)
- Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4‐dihydroxyphenylacetic acid concentration in spiperone‐treated rats (1978) (39)
- Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. (1993) (38)
- Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors. (1975) (38)
- Tissue levels of chloroamphetamines in rats and mice. (1967) (36)
- Daily Rhythm in Plasma Tyrosine and Phenylalanine (1968) (36)
- Preclinical studies on LY228729: a potent and selective serotonin1A agonist. (1993) (35)
- Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (1988) (35)
- Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss. (1992) (35)
- Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain (1995) (35)
- Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism (1975) (34)
- A micromethod for the assay of phenethanolamine N-methyl transferase. (1966) (34)
- Noradrenergic innervation of the cerebellar cortex in normal and in Purkinje cell degeneration mutant mice: Evidence for long term survival following loss of the two major cerebellar cortical neuronal populations (1986) (34)
- Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. (1994) (33)
- Binding of tryptophan to plasma proteins in several species. (1973) (33)
- Elevation of 3, 4‐dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites (1976) (33)
- Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (1985) (32)
- The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding. (1998) (32)
- NEUROCHEMICAL EFFECTS OF SEROTONIN NEUROTOXINS: AN INTRODUCTION (1978) (31)
- Fluoxetine Effects on Serotonin Function and Aggressive Behavior (1996) (31)
- Inhibition of amino acid transaminases by L-cycloserine. (1973) (30)
- Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate. (1992) (30)
- 6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists. (1988) (30)
- Inhibition of monoamine oxidase by N-(phenoxyethyl)cyclopropylamines. Correlation of inhibition with Hammett constants and partition coefficients. (1968) (30)
- STRUCTURE‐ACTIVITY RELATIONSHIPS AMONG THE HALOGENATED AMPHETAMINES (1978) (30)
- Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake. (1975) (29)
- Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. (1993) (29)
- Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats Characterization by the use of antagonists (1984) (29)
- Purkinje cell loss and the noradrenergic system in the cerebellum of pcd mutant mice (1981) (29)
- Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist (1992) (29)
- Tissue distribution, metabolism and effects of bufotenine administered to rats (1995) (28)
- Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. (1986) (28)
- Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. (1997) (27)
- Inhibition of phenethanolamine N-methyl transferase by ring-substituted alpha-methylphenethylamines (amphetamines). (1971) (27)
- Dissociation of the effects of p-chlorophenylalanine on self-stimulation and on brain serotonin. (1970) (27)
- Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships. (1973) (27)
- The response of "obese" (ob-ob) and "diabetic" (db-db) mice to treatments that influence body temperature. (1974) (27)
- Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats. (1986) (26)
- Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857) (1985) (26)
- Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo (1995) (25)
- Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 2. In vitro and in vivo studies with 2,3-dichloro- -methylbenzylamine. (1973) (25)
- Cytidine and deoxycytidylate deaminase inhibition by uridine analogs. (1980) (25)
- Substrate specificity of phenethanolamine N-methyltransferase from rabbit adrenal. (1970) (25)
- d-amphetamine levels in brain and other tissues of isolated and aggregated mice (1967) (24)
- Serotonergic mechanisms in feeding. (1987) (24)
- N-substituted cyclopropylamines as inhibitors of MAO-A and -B forms. (1978) (24)
- Accumulation of amphetamine and p‐chloroamphetamine into synaptosomes of rat brain (1972) (24)
- A POSSIBLE ROLE OF SEROTONIN IN HYPOTHALAMIC SELF-STIMULATION IN DOGS. (1964) (24)
- Studies on the effects on N,N'-dimethylformamide on ethanol disposition and on monoamine oxidase activity in rats. (1977) (24)
- Species differences in epinephrine concentration and norepinephrine N-methyltransferase activity in hypothalamus and brain stem. (1983) (23)
- Striatal dopamine turnover and MIF-I (1979) (23)
- Preclinical studies on LY237733, a potent and selective serotonergic antagonist. (1992) (23)
- Effects of antidepressants on uptake and receptor systems in the brain (1985) (23)
- Formation of α-methylnorepinephrine as a metabolite of metaraminol in guinea pigs (1981) (23)
- Daily Variation in Liver Tryptophan, Tryptophan Pyrrolase, and Tyrosine Transaminase in Rats Fed ad Libitum or Single Daily Meals (1970) (23)
- Behavioral and biochemical effects of p-chlorophenylalanine, 3-chlorotyrosine and 3-chlorotyramine. A proposed mechanism for inhibition of self-stimulation. (1972) (23)
- Regulation of phenylethanolamine N-methyl transferase. (1974) (23)
- Mechanisms and Functions of Serotonin Neuronal Systems (1996) (22)
- Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to mice. (1989) (22)
- Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats. (1981) (22)
- MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. (1986) (22)
- Dopamine accumulation after dopamine beta-hydroxylase inhibition in rat heart as an index of norepinephrine turnover. (1982) (21)
- Biological disposition of rigid analogs of amphetamine. (1977) (21)
- Serotonin concentration and turnover in cerebelum and other brain regions of pcd mutant mice (1988) (21)
- The Pharmacology and Therapeutic Potential of Serotonin Receptor Agonists and Antagonists (1989) (21)
- Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats (1986) (21)
- Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine. (1988) (20)
- Elevation of serum corticosterone in rats by bremazocine, a κ‐opioid agonist (1984) (20)
- Effects of intraventricuear p-chloroamphetamine and its analogues on cerebral 5-HT (1975) (20)
- Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloramphetamine. (1973) (20)
- Serum Uric Acid in Young Mongoloids (1963) (20)
- Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitors (1977) (20)
- Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212. (1996) (20)
- Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive rats (1985) (20)
- α2 andrenoreceptor affinity of some inhibitors of norepinephrine N-methyltransferase (1981) (20)
- Drug disposition as a factor in the lowering of brain serotonin by chloroamphetamines in the rat. (1972) (20)
- Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. (1987) (19)
- Lowering of blood pressure by direct- and indirect-acting serotonin agonists in spontaneously hypertensive rats. (1981) (19)
- N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation. (1968) (19)
- Selectivity among monoamine oxidase inhibitors and its possible importance for development of antidepressant drugs (1978) (19)
- Induction of tyrosine aminotransferase in rat liver by epinephrine and theophylline. (1970) (19)
- The effect of fluoxetine on morphine analgesia, respiratory depression, and lethality (1982) (19)
- (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake. (1995) (19)
- Mechanisms of MPTP (1-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice (1985) (19)
- Serum Corticosterone Increases Reflect Enhanced Uptake Inhibitor‐induced Elevation of Extracellular 5−Hydroxytryptamine in Rat Hypothalamus (1996) (19)
- Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067. (1988) (19)
- Functional Significance of the Sympathetic Nervous System in Production of Hypertension (1969) (19)
- Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats. (1977) (19)
- Dopamine depletion in rat brain by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) (1983) (18)
- Comparison of MPTP and Amphetamines as Dopaminergic Neurotoxins (1992) (18)
- The rise and fall of MTHF as a methyl donor in biogenic amine metabolism. (1976) (18)
- Effect of prazosin on norepinephrine concentration and turnover in rat brain and heart. (1978) (18)
- p-Iodoamphetamine as a serotonin depletor in rats. (1980) (18)
- Inhibition of drug metabolism by fluoxetine. (1976) (18)
- Inhibition of monoamine oxidase action on kynuramine by substrate amines and stereoisomeric α-methyl amines (1965) (17)
- Isolation and purification of rabbit adrenal norephinephrine N-methyl transferase isozymes. (1978) (17)
- Inability of methylphenidate or mazindol to prevent the lowering of 3,4‐dihydroxyphenylacetic acid in rat brain by amphetamine (1979) (17)
- Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers. (1993) (17)
- Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats. (1978) (17)
- Isolation of multiple forms of rabbit-adrenal norepinephrine N-methyltransferase. (1974) (16)
- Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats (1992) (16)
- Studies of noradrenergic influence on cardiac ornithine decarboxylase in rats. (1978) (16)
- Effect of norfenfluramine and two structural analogues on brain 5‐hydroxyindoles and serum prolactin in rats (1982) (16)
- Methiothepin elevation of 5-hydroxyindoleacetic acid levels in various anatomic regions of rat brain. (1974) (15)
- DIFFERENCES IN THE REGULATION OF TYROSINE AMINOTRANSFERASE IN BRAIN AND LIVER (1970) (15)
- Structure-activity correlation for substrates of phenylethanolamine N-methyltransferase (PNMT). (1972) (15)
- New inhibitors of dopamine β-hydroxylase (1977) (15)
- Persistent depletion of striatal dopamine in mice by 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP). (1986) (15)
- Deprenyl protection against striatal dopamine depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (1984) (15)
- Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP (1987) (15)
- The Effect of Aliphatic Fluorine on Amine Drugs (1976) (15)
- Effect of , -difluoro substitution on the disposition and pharmacological effects of 4-chloroamphetamine in rats. (1973) (15)
- On the In‐vivo Modulation of Neostriatal Dopamine Release by Fluoxetine and 5−Hydroxy‐L‐tryptophan in Conscious Rats (1996) (15)
- Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator. (1972) (14)
- Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity. (1989) (14)
- Mechanism by which uptake inhibitors antagonizep-chloroamphetamine-induced depletion of brain serotonin (1980) (14)
- Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice. (1990) (14)
- Microdialysis studies with 5-HT reuptake inhibitors. (1993) (14)
- Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine. (1978) (14)
- Recent studies with 4-chloramphetamine and some analogues. (1974) (14)
- Pharmacological characterization of enantiomers of 8‐thiomethyl‐2‐(di‐n‐propylamino)tetralin, potent and selective 5‐HT1A receptor agonists (1995) (13)
- Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain (2005) (13)
- Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent. (1986) (13)
- Norepinephrine metabolism in the cerebellum of the purkinje cell degeneration (pcd) mutant mouse (1987) (13)
- Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine. (1982) (13)
- Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. (1988) (13)
- Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): differential effects on depletion of heart norepinephrine and of striatal dopamine in mice. (1987) (13)
- Decreased accumulation of brain 5‐hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p‐chloroamphetamine (1983) (12)
- Metabolism of amphetamine and β,β-difluoroamphetamine in phenobarbital-treated rats (1973) (12)
- Substrates and inhibitors of phenyletholamine n-methyl transferase from human adrenal glands (1972) (12)
- INHIBITION OF RAT LIVER TRYPTOPHAN HYDROXYLASE IN VITRO. (1965) (12)
- Nisoxetine antagonism of norepinephrine depletion in brain and heart after α-methyl-m-tyrosine administration (1979) (12)
- Product inhibition studies and the reaction sequence of rabbit adrenal norepinephrine N-methyl transferase isozymes. (1978) (12)
- Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors. (1975) (12)
- Lowering of rat brain 3‐methoxy‐4‐hydroxyphenylethylene glycol sulphate (MOPEG sulphate) concentration by 2,6‐dichlorobenzylidene aminoguanidine (1977) (12)
- Inhibition by p‐chloroamphetamine of the conversion of 5‐hydroxytryptamine to 5‐hydroxyindoleacetic acid in rat brain (1970) (12)
- Disposition and behavioral effects of amphetamine and , -difluoroamphetamine in mice. (1972) (12)
- Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions. (1996) (11)
- RESOLUTION AND ABSOLUTE CONFIGURATION OF AN ERGOLINE-RELATED DOPAMINE AGONIST, TRANS-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H(OR 2H)-PYRAZOLO(3,4-G)QUINOLINE (1983) (11)
- Effect of fluoxetine pretreatment on plasma and tissue concentrations of desipramine in rats. (1989) (11)
- Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats. (1993) (11)
- Inability of an inhibitor of amine uptake (Lilly 110140) to block depletion of brain 5‐hydroxytryptamine by l‐dopa (1975) (11)
- Activity of Phenethanolamine N-Methyl Transferase in the Adrenal Glands of Foetal and Neonatal Rats (1967) (11)
- MK‐801 Protects Against Amphetamine‐Induced Striatal Dopamine Depletion in Iprindole‐Treated Rats, but not Against Brain Serotonin Depletion after p‐Chloroamphetamine Administration (1992) (10)
- Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. (1987) (10)
- Metabolic interactions between nortriptyline and thioridazine in rats. (1974) (10)
- Inhibition in vitro of rabbit adrenal norepinephrine N-methyltransferase by 2,3,4,5-tetrahydro-1H-2-benzazepines. (1979) (10)
- Tropolone antagonism of the l−dopa‐induced elevation of S‐adenosylhomocysteine: S‐adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus (1984) (10)
- Elevation of 3, 4‐dihydroxyphenylacetic acid concentration by L‐5‐hydroxytryptophan in control and fluoxetine‐pretreated rats (1981) (10)
- N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase. (1983) (10)
- L‐Tyrosine enhancement of the elevation of 3,4‐dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid (1982) (10)
- Methylation of norepinephrine and α-methylnorepinephrine in brain (1982) (10)
- Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats. (1981) (9)
- The interaction of rabbit adrenal norepinephrine N-methyl transferase isozymes with substrates. (1978) (9)
- Daily rhythm of liver tyrosine transaminase and of plasma tyrosine and glucose after removal of the pancreas of rats. (1969) (9)
- Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats. (1983) (9)
- Effect of glucagon and p-chlorophenylalanine on hepatic enzymes that metabolize phenylalanine. (1972) (9)
- PHARMACOLOGIC MODIFICATION OF ADRENALINE NEURONS IN RAT BRAIN (1980) (9)
- Selective inhibition of monoamine oxidase. (1972) (9)
- Norepinephrine, monoamine oxidase, and acetylcholinesterase in the rat jugular vein compared with other blood vessels. (1979) (8)
- Comparison of the effects of 6-chloro-2-aminotetralin and of Org 6582, a related chloroamphetamine analog, on brain serotonin metabolism in rats (1977) (8)
- Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders. (1986) (8)
- Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain (1977) (8)
- A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity (1989) (8)
- 6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in rats. (1974) (8)
- MK801 antagonism of the prolonged depletion of striatal dopamine by amphetamine in iprindole-treated rats. (1992) (8)
- Drugs affecting serotonin neurons. (1990) (8)
- Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats (2005) (8)
- Pharmacological profile of LY301317, a potent and selective 5‐HT1A agonist (1997) (8)
- Long-lasting depletion of brain serotonin by 4-chloroamphetamine in guinea pigs. (1974) (8)
- Metabolism of fenfluramine to norfenfluramine in guinea‐pigs (1988) (8)
- Myotonia produced by indoleacetic acid. Studies with related compounds and correlation with drug levels in tissues. (1971) (8)
- Amfonelic acid antagonism of dopamine and norepinephrine depletion by alpha-methyl-m-tyrosine in rat brain. (1981) (7)
- Persistence of long-lasting serotonin depletion by p-chloroamphetamine in rat brain after 6-hydroxydopamine lesioning of dopamine neurons. (1995) (7)
- Quantitation of zinc in nitric acid-digested plasma by atomic absorption spectrophotometry. (1985) (7)
- Inhibition of amine uptake by 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561) in rats. (1976) (7)
- 1-(1-Naphthyl)piperazine, a central serotonin agonist. (1986) (7)
- Studies on the mechanism of amphetamine-induced lipolysis in the rat. (1972) (7)
- Influence of substrate in the inhibition of rat liver and brain monoamine oxidase. (1968) (7)
- Inhibition by disulfiram of the accelerated turnover of catecholamines in the adrenal glands of exercised rats (1968) (7)
- Effects of some homologues of 4-chloroamphetamine on brain serotonin metabolism. (1974) (7)
- An improved method for measuring blood concentrations of phenylpyruvic acid. (1971) (7)
- Long‐lasting reduction of brain 5‐hydroxytryptamine concentration by 3‐chloroamphetamine and 4‐chloroamphetamine in iprindole‐treated rats (1974) (7)
- Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism. (1989) (7)
- Regulation of enzyme activity by glucagon: increased hormonal activity of iodinated glucagon. (1975) (7)
- Selective in Vivo Inhibition of Monoamine Oxidase in Rat Tissues by N-[2-(o-Chlorophenoxy)-Ethyl]-Cyclopropylamine (1978) (7)
- Elevation of hepatic phenylalanine pyruvate aminotransferase in rat by tetraiodoglucagon is blocked by actinomycin D and cycloheximide. (1973) (7)
- Stress. Neurochemical and humoral mechanisms. Volume 1 Edited by G.R. Van Loon, R. Kvetnansky, R. McCarty and J. Axelrod. ISBN 2-88124-339-8. Price: $180.00. Gordon & Breach Science, New York, 1989 (1991) (7)
- Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors. (1985) (7)
- Depletion of epinephrine in rat hypothalamus by Ro 4-1284: Influence of pargyline and harmaline (1980) (7)
- Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats. (1991) (6)
- The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation. (1994) (6)
- Synergistic elevation of brain 3,4‐dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine‐pretreated rats (1979) (6)
- Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats. (1982) (6)
- Effect of pergolide on MOPEG sulphate levels in rat brain regions (1983) (6)
- Lowering of dopamine metabolites in rat brain by harmaline (1981) (6)
- Repeated administration of pergolide to rats attenuates the acute elevation of serum corticosterone by pergolide (1981) (6)
- Norepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines. (1975) (6)
- The brain's three catecholamines (1983) (6)
- Chapter 6. Central Serotonin Receptors: Opportunities for Drug Discovery (1988) (6)
- NEUROENDOCRINE AND BEHAVIORAL STUDIES WITH FLUOXETINE, AN INHIBITOR OF SEROTONIN UPTAKE IN BRAIN (1978) (6)
- Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase. (1981) (6)
- Elevation of serum prolactin acutely after administration of p-chloroamphetamine in rats. (1980) (6)
- Inhibition of rat brain norepinephrine N-methyltransferase by 2,3,4,5-tetrahydro-1H-indeno [1,2-c]-pyridine hydrochloride (LY87130) (1980) (6)
- Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR. (1987) (6)
- Inhibition in vitro of norepinephrine N-methyltransferase by 2-aminotetralins, analogs of phenylethylamines with rigid conformation. (1977) (6)
- Inhibition of rat brain norepinephrineN-methyltransferase by 7,8-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine (1978) (6)
- 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067). (1989) (6)
- Substrate-selective and tissue-selective inhibition of monoamine oxidase. (1972) (6)
- Comparative 5‐HT2‐Receptor Antagonist Activity of Amesergide and its Active Metabolite 4‐Hydroxyamesergide in Rats and Rabbits (1994) (5)
- Procaine Hydrochloride as a Monoamine Oxidase Inhibitor: Implications for Geriatric Therapy (1977) (5)
- Pharmacologic properties of serotonergic agents and antidepressant drugs. (1987) (5)
- LOWERING OF BRAIN EPINEPHRINE BY INHIBITION OF NOREPINEPHRINE N-METHYLTRANSFERASE IN RATS (1979) (5)
- Inability of methadone to prevent the depletion of brain 5-hydroxyindoles by p-chloroamphetamine. (1976) (5)
- Persistent effects of amphetamine, p-chloroamphetamine, and related compounds on central dopamine and serotonin neurons in rodents. (1985) (5)
- Effects of LY104119, a thermogenic weight-reducing compound, on norepinephrine concentrations and turnover in obese and lean mice. (1988) (5)
- Tissue levels of metaraminol and its metabolite, alpha-methylnorepinephrine, in control and 6-hydroxydopamine-pretreated guinea pigs. (1981) (5)
- Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain (1981) (4)
- Flumezapine and zotepine: 5‐hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats (1985) (4)
- Fluoxetine: a clinically effective non-tricyclic antidepressant (1983) (4)
- The role of metabolic N‐dealkylation in the action of p‐chlorometham‐phetamine and related drugs on brain 5‐hydroxytryptamine (1977) (4)
- Effect of glucagon and dibutyryl cyclic AMP on the tissue distribution of [14C] α‐aminoisobutyric acid in rats (1975) (4)
- Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone (1982) (4)
- Formation of alpha-methylnorepinephrine as a metabolite of metaraminol in guinea pigs. (1981) (4)
- Effect of lergotrile on3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain (2005) (4)
- p-Chloroamphetamine formation responsible for long-term depletion of brain serotonin after N-cyclopropyl-p-chloroamphetamine injection in rats. (1987) (4)
- Elevation of hepatic phenylalanine: pyruvate aminotransferase by dibutyryl cyclic AMP in rats. (1974) (4)
- Hepatic insensitivity to glucagon in ob/ob mice. (1980) (4)
- Antagonism by tomoxetine of the depletion of norepinephrine and epinephrine in rat brain by alpha-methyl-m-tyrosine. (1983) (4)
- Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP. (1992) (4)
- Effect of fluoxetine pretreatment on the neurochemical changes induced by amfonelic acid combined with spiperone in rats (1986) (4)
- Inhibition of norepinephrine N-methyltransferase by 1-aminoindans, conformationally rigid analogs of benzylamines. (1978) (4)
- MPTP: A Parkinsonism-causing Neurotoxic Substance (1990) (4)
- Chapter 3. Progress in Antidepressant Drugs (1991) (4)
- The Place of Animal Models and Animal Experimentation in the Study of Food Intake Regulation and Obesity in Humans (1987) (4)
- Comparison of fluoxetine and norfluoxetine enantiomers as inhibitors of hexobarbitone metabolism in mice. (1992) (4)
- Decreased 5‐hydroxytryptamine turnover in striatum and other brain regions after administration of 5‐methoxy‐3‐(di‐n‐propylamino)‐chroman to rats (1989) (4)
- Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists (1985) (3)
- Central serotonin antagonist activity of ketanserin. (1984) (3)
- Increased conversion of a phenylalanine load to tyrosine in tetraiodoglucagon-treated rats. (1974) (3)
- CATECHOLAMINE CONCENTRATION IN THE CEREBELLUM OF PURKINJE CELL DEGENERATION (pcd) MUTANT MICE (1980) (3)
- Phenethanolamine N-methyl transferase and adrenocortical activity in the neonatal rat. (1969) (3)
- Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatment (1979) (3)
- In vivo effects of LR5182, cis-3-(3,4-dichlorophenyl)-2-N,N-dimethylaminomethyl-bicyclo-[2,2,2]-octane hydrochloride, an inhibitor of uptake into dopamine and norepinephrine neurons (1979) (3)
- Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brain. (1977) (3)
- Increase in serum corticosterone concentration and decrease in hypothalamic epinephrine concentration by N-propylnorapomorphine in rats. (1984) (3)
- Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain. (1983) (3)
- Functional consequences of inhibiting serotonin uptake with fluoxetine in rats. (1982) (3)
- Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats. (1995) (3)
- Properties of norepinephrine N-methyltransferase from rat, cat and chicken brain. (1979) (3)
- Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (1985) (3)
- Neurochemical effects of CM 57227 and CM 57373, two anorectic agents, on brain serotonin neurons in rats (1990) (3)
- Species difference in the lowering of brain 5‐hydroxytryptamine by m‐chloroamphetamine (1972) (3)
- Depletion of brain serotonin by chronic administration of p-chloramphetamine orally to rats and dogs. (1979) (3)
- Comparative brain levels of phenylpropanolamine and amphetamine in rats. (1992) (2)
- Brain Monoaminergic Neurons: Distribution and Function in Relation to Regulation of Autonomic, Neuroendocrine and Immune Systems (1986) (2)
- Duration of the effects of α‐ethyl‐4‐methyl‐m‐tyramine, (H75/12) on brain 5‐hydroxyindole concentrations in rats (1976) (2)
- 5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase. (1974) (2)
- Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine, an analog of MPTP, on mouse heart norepinephrine and brain catecholamines (1993) (2)
- Role of type A and Type B MAO in the metabolism of epinephrine in rat brain (1981) (2)
- Modification by harmaline of the effects of N‐cyclopropyl‐p‐chloroamphetamine on 5‐hydroxyindole concentration in rat brain (1979) (2)
- Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor (2005) (2)
- Antagonism by L-dopa of the elevation of hypothalamic epinephrine by monoamine oxidase inhibition in rats. (1981) (2)
- Effect of mazindol on brain dopamine turnover in spiperone-treated rats (2005) (2)
- Pharmacology of para-chloroamphetamine and analogs. (1976) (2)
- Comparison of o-octopamine and related phenylethanolamines as substrates for norepinephrine N-methyltransferase. (1981) (2)
- Ihibition of rat brain norepinephrine N-methyltransferase in vitro and in vivo by chloro-substituted 1-aminoindans. (1980) (2)
- AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats. (1988) (2)
- [76] Norepinephrine N-methyltransferase from rabbit adrenal glands (1987) (2)
- Studies on 4-(p-bromophenyl)-bicyclo (2,2,2) octan-1-amine as an inhibitor of uptake into serotonin neurones (1978) (2)
- Antagonism by (−)‐methadone of the depletion of 5‐hydroxytryptamine in rat brain by p‐chloroamphetamine (1981) (2)
- Antagonism of Serotonin Agonist-Elicited Increases in Serum Corticosterone Concentration in Rats (1991) (2)
- 6-Substituted 1,3,4,5-Tetrahydrobenz(cd)indol-4-amines: Potent Serotonin Agonists. (1989) (2)
- Substituted phenylpiperazines as serotonin agonists: structural determinants of potency and interaction with receptor subtypes. (1986) (2)
- Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions. (1977) (2)
- Studies on maxindol as an amine uptake inhibitor. (1978) (2)
- 5'-THIODENOSINE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF HISTAMINE N-METHYL-TRANSFERASE (1989) (2)
- Influence of PKa on the methylation of arylalkylamines by rabbit lung N-methyltransferase. (1975) (2)
- SPECIFICITY IN THE INHIBITION OF MONOAMINE UPTAKE (1984) (1)
- Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase. (1983) (1)
- Effect of phenobarbital on the metabolism and serotonin-depleting action of 4-chloro-beta, beta-difluoroamphetamine in rats. (1974) (1)
- Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist. (1984) (1)
- Fenfluramine and Parkinson's disease. (1977) (1)
- Inability of monoamine oxidase inhibitors to prevent to persistent depletion of striatal dopamine by amphetamine in rats (1984) (1)
- Norepinephrine N-methyltransferase from rabbit adrenal glands. (1987) (1)
- Effect of some lipid‐soluble derivatives of amphetamine on amphetamine levels in rat brain (1973) (1)
- alpha 2 Adrenoreceptor affinity of some inhibitors of norepinephrine N-methyltransferase. (1981) (1)
- Effect of glucagon and dibutyryl cyclic AMP on the tissue distribution of [14-C] alpha-aminoisobutyric acid in rats. (1975) (1)
- Properties of norepinephrine N-methyltransferase from pigeon brain (1979) (1)
- Antidiarrhoeal effects of quipazine and 1‐(m‐trifluoromethyl‐phenyl)piperazine in mice (1981) (1)
- Methylation of norepinephrine and alpha-methylnorepinephrine in brain. (1982) (1)
- Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine. (1978) (1)
- Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in mice. (1990) (1)
- INHIBITION OF MONOAMINE OXIDASE ACTION ON KYNURAMINE BY SUBSTRATE AMINES AND STEREOISOMERIC ALPHA-METHYL AMINES. (1965) (1)
- Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats. (1981) (1)
- Recommendations for future research on amphetamines and related designer drugs. (1989) (1)
- Drug Discovery at the Enzyme Level (1987) (1)
- CNS stimulant properties and physiologic disposition of Β,Β-difluorophenylethylamine in mice (2004) (1)
- Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). (1987) (1)
- Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats. (1973) (1)
- Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide (1982) (1)
- Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake. (1974) (1)
- Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. (1986) (1)
- Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats (1988) (1)
- Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content. (1996) (1)
- Dissociation of the lipid mobilizing and hyperthermic effects of amphetamine by beta-fluoro substitution. (1972) (1)
- Effect of uptake inhibitors on the depletion of brain norepinephrine and serotonin after alpha-methyl-m-tyrosine administration to rats. (1978) (1)
- Effect of 2-(p-chlorophenyl)cyclopropylamine on 5-hydroxyindole concentration and monoamine oxidase activity in rat brain. (1980) (1)
- Analogue of fluoxetine. (1989) (0)
- GENERAL DISCUSSION (1978) (0)
- Inhibition of monoamine oxidase by 3-amino-2-oxazolidinone and 2-hydroxy-ethylhydrazine (1971) (0)
- Effect of p-chloroamphetamine on serotonin content of the rat pineal gland. (1977) (0)
- Position of a chloro substituent on phenylethanolamine as a determinant of methylation by rabbit adrenal norepinephrine N-methyltransferase. (1977) (0)
- Daily cyclic variation in liver tyrosine alpha-ketoglutarate trans- aminase (tkt) in rats and mice. Abstr. (1968) (0)
- Fluoxetine analogs, process for their preparation and to pharmaceutical compositions containing such (1989) (0)
- An ImprovedMethodfor MeasuringBlood Concentrationsof Phenylpyruvic Acid (2004) (0)
- Ionophore (A23187)-induced efflux of [3H]norepinephrine and endogenous norepinephrine in the rat vas deferens. (1981) (0)
- Elevation of hepatic tyrosine 2-oxoglutarate aminotransferase in rats by 4-pentynoic acid, a hypoglycemic agent (1973) (0)
- Serotonergic drugs increase mhpg sulfate in rat hypothalamus (1991) (0)
- Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brain. (1978) (0)
- Dialysis rate as a rapid measurement of tryptophan binding to albumin. (1974) (0)
- New inhibitors of dopamine beta-hydroxylase. (1976) (0)
- Effect of cis and trans isomers of 1-amino-2-(p-chlorophenyl)cyclohexane, conformationally restricted analogs of p-chloroamphetamine, on 5-hydroxyindoles in rat brain. (1982) (0)
- Methylation of non-phenyl ethanolamines by norepinephrine N-methyltransferase. (1977) (0)
- Endocrine and neurochemical effects of (+)-PHNO, a dopamine D2 agonist (2005) (0)
- The atypical antipsychotic olanzapine blocks muscarinic, serotonergic and dopamine receptors (1995) (0)
- AnImproved MethodforMeasuring Blood Concentrations ofPhenylpyruvic Acid (1971) (0)
- Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in rats. (1992) (0)
- Norepinephrine N-methyltransferase in brain (1982) (0)
- Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain. (1980) (0)
- Preliminary report on use of sulfamethazine and penicillin in bovine mastitis. (1949) (0)
- 5'-thioadenosine derivatives as potent and selective inhibitors of histamine N-methyltransferase. (1989) (0)
- Sensitization to dopamine (DA) and 5-hydroxy-tryptamine (5-HT) agonists is not correlated with alterations in DA and 5-HT contents of neostriatum after neonatal intrastriatal 6-hydroxydopamine injections in rats (1995) (0)
- Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart. (1988) (0)
- SAT-5-4 Olanzapine: An exciting atypical antipsychotic — the preclinical profile (1995) (0)
- PURIFICATION AND PROPERTIES OF ANTIPLASMIN FROM BOVINE AND HUMAN BLOOD SERUMS (1961) (0)
- Comparison of some conformationally rigid benzylamine analogs as substrates for rabbit lung N-methyltransferase. (1980) (0)
- Comparison of the rates of N-methylation of norepinephrine and alpha-methylnorepinephrine by brain stem homogenates from three species. (1983) (0)
- Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline. (1983) (0)
- Effect of cycloserine stereoisomers and theophylline on the release of tritium from 2-tritio-L-alanine. (1976) (0)
- Potent in vivo but not in vitro inhibition of monoamine oxidase by 3-chloro-α-phenylpyrazinemethanol (1992) (0)
- Metabolism of amphetamine and beta,beta-difluoroamphetamine in phenobarbital-treated rats. (1973) (0)
- FLUOXENTINE, A SELECTIVE INHIBITOR OF SEROTONIN UPTAKE IN ANIMAL STUDIES (1984) (0)
- Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine. (1978) (0)
- NOREPINEPHRINE N‐METHYLTRANSFERASE INHIBITION BY BENZAMIDINES, PHENYLACETAMIDINES, BENZYLGUANIDINES, AND PHENYLETHYLGUANIDINES (1975) (0)
- Of dihydrolysergic acid esters, process for their preparation, intermediates for use thereby, and compositions containing the active compounds (1986) (0)
- A process for the preparation of 9,10- dihydrolysergic acid esters. (1986) (0)
- Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference. (1978) (0)
- Letter: Effect of some lipid-soluble derivatives of amphetamine on amphetamine levels in rat brain. (1973) (0)
- Inability of imipramine to protect against type A or type B monoamine oxidase inhibition by pargyline. (1979) (0)
- Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats. (1978) (0)
- Circulation Research provides a medium for bringing together basic research on the cardiovascular sys- tem from various disciplines including biology, biochemistry, biophysics, morphology, pathology, physiology, and pharmacology. The Journal also will accept for publication manuscripts on clinical r (1977) (0)
- Phenylpropanolamine and amphetamine: comparative effects on striatal dopamine neurons in iprindole-treated rats (1983) (0)
- Role of Serotonin in Regulation of the Pituitary-Adrenocortical Axis in Rats (1990) (0)
- Note on the Constitution of Diparabromben-Zylcyanamide (0)
- In Vivo Cardiovascular Responses to Isoproterenol, Dopamine, and Tyramine Following Prolonged Infusion of Isoproterenol (1986) (0)
This paper list is powered by the following services: